RESUMEN
We have used adenoviral-mediated gene transfer of a constitutively active (V12rac1) and dominant negative (N17rac1) isoform of rac1 to assess the role of this small GTPase in cardiac myocyte hypertrophy. Expression of V12rac1 in neonatal cardiac myocytes results in sarcomeric reorganization and an increase in cell size that is indistinguishable from ligand-stimulated hypertrophy. In addition, V12rac1 expression leads to an increase in atrial natriuretic peptide secretion. In contrast, expression of N17rac1, but not a truncated form of Raf-1, attenuated the morphological hypertrophy associated with phenylephrine stimulation. Consistent with the observed effects on morphology, expression of V12rac1 resulted in an increase in new protein synthesis, while N17rac1 expression inhibited phenylephrine-induced leucine incorporation. These results suggest rac1 is an essential element of the signaling pathway leading to cardiac myocyte hypertrophy.
Asunto(s)
Cardiomegalia/fisiopatología , Proteínas de Unión al GTP/fisiología , Miocardio/citología , Transducción de Señal/fisiología , Adenoviridae/genética , Animales , Animales Recién Nacidos , Factor Natriurético Atrial/metabolismo , Proteínas Quinasas Dependientes de Calcio-Calmodulina/análisis , Tamaño de la Célula/fisiología , Células Cultivadas , Técnica del Anticuerpo Fluorescente , GTP Fosfohidrolasas/fisiología , Regulación de la Expresión Génica/fisiología , Técnicas de Transferencia de Gen , Fenilefrina/farmacología , Biosíntesis de Proteínas , Proteínas Proto-Oncogénicas c-raf/fisiología , Ratas , Ratas Sprague-Dawley , Sarcómeros/ultraestructura , Proteínas de Unión al GTP racRESUMEN
We demonstrate that adenoviral-mediated gene transfer of a dominant negative rac1 gene product (N17rac1) inhibits the intracellular burst of reactive oxygen species (ROS) that occurs after reoxygenation of vascular smooth muscle cells. In contrast, expression of a dominant negative ras gene (N17ras) had no effect. Challenge of control cells and cells expressing N17rac1 with a direct oxidant stress produced an equivalent increase in intracellular ROS levels and subsequent cell death. This suggests that N17rac1 expression appears to block production of harmful oxygen radicals and does not act directly or indirectly to scavenge ROS generated during reoxygenation. Expression of N17rac1 results in protection from hypoxia/reoxygenation-induced cell death in a variety of cell types including vascular smooth muscle cells, fibroblasts, endothelial cells, and ventricular myocytes. These results suggest that reoxygenation injury requires the activation of rac proteins, and that inhibition of rac-dependent pathways may be a useful strategy for the prevention of reperfusion injury in ischemic tissues.
Asunto(s)
Proteínas de Unión al GTP/antagonistas & inhibidores , Músculo Liso Vascular/efectos de los fármacos , Oxígeno/farmacología , Aerobiosis , Anaerobiosis , Animales , Aorta/citología , Muerte Celular/efectos de los fármacos , Células Cultivadas , Depuradores de Radicales Libres , Proteínas de Unión al GTP/genética , Humanos , Músculo Liso Vascular/patología , Ratas , Especies Reactivas de Oxígeno/metabolismo , Proteínas Recombinantes/antagonistas & inhibidores , Daño por Reperfusión/prevención & control , Transducción de Señal , Venas Umbilicales/citología , Proteínas de Unión al GTP rac , Proteínas ras/metabolismoRESUMEN
We have identified a cellular enhancer-binding protein, present in nuclear extracts prepared from human and rodent cells, that binds to the adenovirus E1A enhancer element I sequence. The factor has been termed EF-1A, for enhancer-binding factor to the E1A core motif. EF-1A was found to bind to two adjacent, related sequence motifs in the E1A enhancer region (termed sites A and B). The binding of EF-1A to these adjacent sites, or to synthetic dimerized sites of either motif, was cooperative. The cooperative binding of EF-1A to these sites was not subject to strict spacing constraints. EF-1A also bound to related sequences upstream of the E1A enhancer region and in the polyomavirus and adenovirus E4 enhancer regions. The EF-1A-binding region in the E1A enhancer stimulated expression of a linked gene in human 293 cells when multimerized. Based on the contact sites for EF-1A binding determined by chemical interference assays, this protein appears to be distinct from any previously characterized nuclear binding protein.
Asunto(s)
Adenoviridae/genética , Proteínas de Unión al ADN/genética , Elementos de Facilitación Genéticos , Transcripción Genética , Animales , Secuencia de Bases , Sitios de Unión , Unión Competitiva , Electroforesis en Gel de Poliacrilamida , Células HeLa , Humanos , Datos de Secuencia Molecular , MutaciónRESUMEN
We examined the effect of overexpression of growth factor-regulated second messenger enzymes, alone and in combination, on transformation of NIH3T3 cells. Signal transducers included phospholipase C-gamma (PLC-gamma), protein kinase C-gamma (PKC-gamma), and two proto-oncogenes, c-H-ras and c-raf-1. Three of these proteins, PLC-gamma, PKC-gamma and Raf-1, did not transform NIH3T3 cells alone or in combination. c-H-ras, which under its own promoter control has low transforming activity, also did not cooperate with PLC-gamma or PKC-gamma. In contrast, the combination of normal or oncogenic p21 H-Ras with the Raf-1 kinase dramatically increased transformation efficiency. The level of Ras protein required for transformation was reduced in Raf-1 co-transfectants, implying that, at low levels of p21 Ras, p74 Raf-1 is rate limiting. As transformation by Ras depends on jun-mediated transcriptional events, we also examined H-ras and c-raf-1 cooperation in transcriptional transactivation of TPA-responsive element (TRE)-dependent reporters. Like the H-ras/c-raf-1 cooperation in transformation, we observed this synergistic stimulation of TRE-dependent transcription. This pathway for transformation and transcriptional activation by increased levels of normal Ras and Raf may be important in tumors that show overexpression but lack mutationally activated forms of these two proto-oncogenes.
Asunto(s)
Transformación Celular Neoplásica/genética , Genes ras , Proteínas Proto-Oncogénicas p21(ras)/metabolismo , Proteínas Proto-Oncogénicas/genética , Células 3T3 , Animales , Expresión Génica , Sustancias de Crecimiento/fisiología , Técnicas In Vitro , Ratones , Proteína Quinasa C/fisiología , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-raf , Sistemas de Mensajero Secundario , Transcripción Genética , Transfección , Fosfolipasas de Tipo C/fisiologíaRESUMEN
A dominant negative mutant of Ras, M17 Ras, was used to study the role of Ras in receptor coupling of Raf-1 and B-Raf protein serine/threonine kinases (PSKs). We found that mutant Ras blocks serum- and 12-O-tetradecanoyl phorbol 13-acetate-induced activation of Raf-1 kinase in NIH3T3 cells and Raf-1 as well as B-Raf PSK stimulation by nerve growth factor (NGF) in PC12 pheochromocytoma cells. Mitogen stimulation of Raf kinase was measured by determination of Raf hyperphosphorylation and activity towards exogenous substrates and both of these events were inhibited in cells expressing M17 Ras. In contrast, tyrosine phosphorylation of a direct substrate of activated tyrosine kinase receptors, phospholipase C-gamma 1 (PLC-gamma 1), was unaffected. These data indicate that tyrosine phosphorylation of PLC-gamma 1 is not sufficient for growth induction in NIH3T3 cells and that Ras mediates signal transfer from activated membrane receptors to Raf kinases in the cytosol. As activated Raf induced differentiation in PC12 cells expressing M17 Ras we conclude that Raf kinase activation may be sufficient to account for this aspect of NGF function.
Asunto(s)
Genes ras , Proteína Quinasa C/fisiología , Proteínas Quinasas/fisiología , Proteínas Proto-Oncogénicas/fisiología , Células 3T3 , Secuencia de Aminoácidos , Animales , Fenómenos Fisiológicos Sanguíneos , Citosol/metabolismo , Dexametasona/farmacología , Receptores ErbB/fisiología , Ratones , Datos de Secuencia Molecular , Factores de Crecimiento Nervioso/farmacología , Fosforilación , Proteínas Serina-Treonina Quinasas , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-raf , Receptor de Factor Estimulante de Colonias de Macrófagos/fisiología , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
Adenoviruses began to be developed into highly effective gene expression vectors in the early 1980s. Recently, the increased interest in utilizing this transfer system in vivo has posed new problems for heterologous gene-transfer, spurring a renewed effort in the field of vector development toward solving the structural, immunological and targeting problems posed by gene therapy applications.
Asunto(s)
Adenoviridae/genética , Vectores Genéticos , Proteínas Recombinantes/biosíntesis , Transfección/métodos , Animales , Formación de Anticuerpos , Citocinas/biosíntesis , Terapia Genética/métodos , Humanos , Inmunidad Celular , Inmunoterapia/métodosRESUMEN
Proapoptotic adenovirus vectors offer great promise for the treatment of cancer and nonmalignant conditions. Benign prostate hyperplasia (BPH) is a common nonmalignant enlargement of the prostate that involves epithelial, stromal, and smooth muscle components of the gland. We tested the hypothesis that an adenovirus vector expressing Fas ligand can be used to induce apoptosis in the prostate. We analyzed the efficiency of transduction and apoptosis induction in primary cultures of human prostate cells after adenovirus-mediated gene transfer. Efficient transduction was observed in primary prostate epithelial cells. Stromal and smooth muscle cells were more difficult to transduce, as no coxsackie-adenovirus receptor (CAR) expression was detectable on these cells. However, transduction was achieved in these cells when the multiplicity of infection was increased to 100 focal-forming units per cell, or when the vectors were delivered as calcium phosphate precipitates. Infection of all three primary prostate cell types with an adenovirus vector that expresses Fas ligand (AdFasL/G) resulted in rapid apoptosis. Direct injection of the rat prostate with an adenovirus vector carrying luciferase resulted in substantial luciferase expression. TUNEL analysis demonstrated that AdFasL/G administration induced low-level apoptosis in prostatic epithelial cells throughout the gland. As a first step toward enhancing the efficiency of prostate transduction in vivo, we tested an adenovirus vector that was engineered to have an expanded tropism. This vector, AdZ.F2K(pK7), was 10- to 500-fold more efficient than unmodified vectors in transducing prostate epithelial, smooth muscle, and stromal cells in culture. Moreover, AdZ.F2K(pK7) was more efficient than an unmodified vector at transducing the rat prostate in vivo, although the effect was dose dependent.
Asunto(s)
Adenoviridae/genética , Apoptosis , Vectores Genéticos , Hiperplasia/terapia , Próstata/metabolismo , Transducción Genética , Animales , Fosfatos de Calcio/metabolismo , Células Cultivadas , Relación Dosis-Respuesta a Droga , Células Epiteliales/metabolismo , Proteína Ligando Fas , Citometría de Flujo , Vectores Genéticos/genética , Humanos , Etiquetado Corte-Fin in Situ , Luciferasas/metabolismo , Masculino , Glicoproteínas de Membrana/genética , Músculo Liso/citología , Músculo Liso/metabolismo , Poli(ADP-Ribosa) Polimerasas/metabolismo , Próstata/patología , Ratas , Células Tumorales Cultivadas , beta-Galactosidasa/metabolismoRESUMEN
Adenovirus vectors expressing gene products that can induce apoptosis have potential utility in gene therapy applications ranging from the treatment of proliferative diseases to transplantation. However, adenovirus vectors carrying proapoptotic gene products are difficult to produce, as the apoptotic environment is not conducive to adenovirus gene expression and replication. Production of AdFasL/G, an adenovirus vector that expresses high levels of Fas ligand, was severely reduced in the 293 packaging cell line. Increased yields of AdFasL/G were achieved by inclusion of peptide-based caspase inhibitors in the growth medium. However, use of these inhibitors for large-scale production would be difficult and expensive. A screen for gene products that increase the yield of AdFasL/G in 293 cells revealed that the poxvirus serpin CrmA and the adenovirus 14.7K product were able to increase virus yields significantly. Apoptosis induced by AdFasL/G was attenuated in 293CrmA cell lines and virus titers were increased dramatically. However, serial passage of AdFasL/G on 293CrmA cells resulted in the generation of replication-competent adenovirus. To resolve this problem, the CrmA gene was introduced into AE25 cells, an E1-complementing cell line that has limited sequence identity with the vectors. AdFasL/G titers were increased 100-fold on AE25CrmA cells relative to the AE25 cells and RCA contamination was not detectable. In addition, adenovirus vectors that express FADD, caspase 8, and Fas/APO1 were produced efficiently in AE25CrmA and 293CrmA.
Asunto(s)
Adenoviridae/genética , Apoptosis/genética , Vectores Genéticos , Transgenes , Apoptosis/efectos de los fármacos , Inhibidores de Caspasas , Inhibidores de Cisteína Proteinasa/farmacología , Humanos , Etiquetado Corte-Fin in Situ , Células Tumorales CultivadasRESUMEN
AIM: To investigate the efficacy of "ex vivo" adenoviral vector mediated gene transfection of human conjunctival epithelial cell as a possible route for gene therapy for the distribution of anti-inflammatory agents for the potential treatment of immune mediated ocular inflammatory disorders. METHODS: Human conjunctival cells (HCs) were cultured with various concentrations of recombinant adenoviral vectors carrying a reporter gene LacZ, GFP, or an immunomodulating cytokine vIL-10. vIL-10 in culture supernatant was detected by sandwich ELISA and biological activity was assessed by suppression of ConA stimulated splenocyte proliferation. X-gal and GFP expression was assessed by histochemistry. RESULTS: The extent of adenoviral vector mediated transfer of both reporter genes and vIL-10 was dose dependent. LacZ expression could be detected for at least 50 day after infection with multiple of infection (MOI) 200. Following AdCMVvIL-10 transduction, vIL-10 protein expression occurred between 4-6 days post-transduction, and was maintained at a detectable level for at least 1 month. Secreted vIL-10 showed biological activity, significantly inhibiting Con A induced splenocyte proliferation. Additionally, transfection of HCs with two Adv vectors, one carrying LacZ and the other carrying GFP, resulted in co-expression within a single cell. CONCLUSION: These results confirm previous successful adenoviral vector mediated gene transfer to HCs and further show that expression can be maintained. Furthermore the data show HCs can secrete biologically active vIL-10 that could be developed as a strategy to suppress immune mediated disorders. The successful co-transduction of HCs as described for other tissues, opens avenues to develop a multiple target gene therapy locally.
Asunto(s)
Adenoviridae/genética , Conjuntivitis Alérgica/terapia , Vectores Genéticos/administración & dosificación , Interleucina-10/genética , Transducción Genética/métodos , Animales , División Celular , Células Cultivadas , Medios de Cultivo Condicionados/farmacología , Proteínas Fluorescentes Verdes , Humanos , Interleucina-10/análisis , Proteínas Luminiscentes/genética , Ratones , Ratones Endogámicos C57BL , Bazo/citologíaRESUMEN
A cellular nuclear factor, EF-1A, binds to a sequence motif which is repeated in the adenovirus type 5 E1A transcriptional control region. Previous genetic analyses demonstrated that two of these binding sites are predominant functional elements of the E1A enhancer region in vivo. In this report, we demonstrate that the cooperative binding of EF-1A to neighboring sites in the E1A enhancer region results in a synergistic activation of E1A transcription in infected cells.
Asunto(s)
Infecciones por Adenoviridae/microbiología , Proteínas de Unión al ADN/metabolismo , Regulación Viral de la Expresión Génica , Proteínas Nucleares/metabolismo , Proteínas Oncogénicas Virales/genética , Factores de Transcripción/metabolismo , Proteínas Precoces de Adenovirus , Secuencia de Bases , Línea Celular , Proteínas de Unión al ADN/farmacología , Sinergismo Farmacológico , Elementos de Facilitación Genéticos , Regulación Viral de la Expresión Génica/efectos de los fármacos , Humanos , Técnicas In Vitro , Datos de Secuencia Molecular , Proteínas Nucleares/farmacología , Unión Proteica , ARN Viral/biosíntesis , Secuencias Reguladoras de Ácidos Nucleicos , Factores de Transcripción/farmacología , Transcripción Genética/efectos de los fármacosRESUMEN
Previous studies have shown that airway administration of adenovirus or adenovirus vectors results in a dose-dependent inflammatory response which limits the duration of transgene expression. We explored the possibility that adenovirus infection triggers signal transduction pathways that induce the synthesis of cytokines and thus contribute to the early inflammatory response. Since stimulation of the Raf/mitogen-activated protein kinase (MAPK) pathway activates transcription factors that control the expression of inflammatory cytokines, we examined the activation of this pathway following adenovirus infection. Adenovirus infection induced the rapid activation of Raf-1 and a transient increase in the tyrosine phosphorylation and activation of p42mapk at early times postinfection. Activation of the Raf/MAPK pathway by adenovirus is likely triggered by the infection process, since it occurred rapidly and with various mutant adenoviruses and adenovirus vectors. Moreover, interleukin-8 (IL-8) mRNA accumulation was evident at 20 min postinfection and was induced even in the presence of cycloheximide. Both MAPK activation and IL-8 production were inhibited by forskolin, a potent inhibitor of Raf-1. These results suggest that adenovirus-induced Raf/MAPK activation contributes to IL-8 production. Adenovirus-induced activation of the Raf/MAPK signaling pathway and IL-8 production may play critical roles in the inflammation observed following in vivo administration of adenovirus vectors for gene therapy.
Asunto(s)
Adenovirus Humanos/metabolismo , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Interleucina-8/biosíntesis , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Transducción de Señal/fisiología , Línea Celular Transformada , Células HeLa , Humanos , Proteína Quinasa 1 Activada por Mitógenos , Proteínas Proto-Oncogénicas c-rafRESUMEN
The human transcription factor EF-1A binds to the purine-rich E1A core enhancer sequence in the adenovirus E1A and E4 and polyomavirus enhancer regions. The consensus binding site for EF-1A resembles that of members of the ets domain protein family. EF-1A activation of transcription requires a dimeric binding site. Analysis of binding sites containing point mutations revealed that EF-1A binding is determined by the core nucleotides of the binding site, while transcriptional activation is determined both by the core and some peripheral nucleotides that do not affect binding. We have purified EF-1A and analyzed its two constituent subunits, EF-1A alpha and EF-1A beta. EF-1A alpha (MW approximately 60kD) makes the primary DNA contacts. EF-1A beta (MW approximately 50 kD) forms a heteromultimeric complex with EF-1A alpha both in solution and on a dimeric binding site. Binding of both EF-1A subunits is necessary, but not sufficient, for transcriptional activation. We present immunochemical and functional evidence that EF-1A alpha is related to the murine ets-related protein GABP alpha and that EF-1A beta is related to the murine protein GABP beta.
Asunto(s)
Adenoviridae/genética , Proteínas E1A de Adenovirus/genética , Elementos de Facilitación Genéticos , Proteínas Nucleares/metabolismo , Poliomavirus/genética , Factores de Transcripción/metabolismo , Proteínas E4 de Adenovirus/genética , Secuencia de Bases , Sitios de Unión , Núcleo Celular/metabolismo , Electroforesis en Gel de Poliacrilamida , Genes Virales , Células HeLa , Humanos , Sustancias Macromoleculares , Datos de Secuencia Molecular , Peso Molecular , Proteínas Nucleares/aislamiento & purificación , Sondas de Oligonucleótidos , Factores de Transcripción/aislamiento & purificación , Transcripción GenéticaRESUMEN
Raf-1 serine-threonine protein kinase has the hallmarks of a critical switch that connects growth factor receptor activation at the cell membrane with transcriptional events in the nucleus. We show by use of Raf-1 dominant-negative mutants that Raf-1 is required for serum-, TPA-, and Ras-induced expression from the oncogene-responsive element in the polyomavirus enhancer. The minimal region of Raf-1 that displays this dominant-negative phenotype (Raf-C4) contains a cysteine finger motif. Raf-C4 appears to function by titrating out a Raf-1-activating factor that is induced by Ras following serum or TPA treatment of NIH-3T3 cells. In addition, we show that Raf-1 and Ras cooperate in trans-activation through the oncogene-responsive element and that the cysteine-rich region is necessary for this effect.
Asunto(s)
Expresión Génica , Genes ras , Regiones Promotoras Genéticas , Proteínas Proto-Oncogénicas/metabolismo , Acetato de Tetradecanoilforbol/farmacología , Células 3T3 , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Cloranfenicol O-Acetiltransferasa/genética , Elementos de Facilitación Genéticos , Genes Virales , Ratones , Datos de Secuencia Molecular , Mutación , Poliomavirus/genética , Proteínas Proto-Oncogénicas c-raf , Homología de Secuencia de Ácido Nucleico , Activación TranscripcionalRESUMEN
Effective repeat administration of adenovirus vectors following intranasal or intravenous delivery is hindered by a strong neutralizing antibody response to the vector. Intramuscular administration of adenovirus vectors elicited a neutralizing antibody response that peaked between 14 and 21 days after infection. However, effective repeat intramuscular administration of adenovirus vectors was not hindered by the presence of neutralizing antibodies in the serum. Surprisingly, beta-galactosidase expression in the skeletal muscle of immunized mice was equivalent to that observed in control mice. As expected, these serum neutralizing antibodies effectively blocked repeat administration of adenovirus vectors when delivered via the intravenous route. These results were observed in both C57BL/6 and Balb/c mice and thus do not appear to be strain specific. Successful repeat administration of adenovirus vectors to skeletal muscle has significant implications for the use of adenovirus vectors clinically and for increasing the safety and efficacy of adenovirus vector gene delivery.
Asunto(s)
Adenoviridae/genética , Terapia Genética/métodos , Vectores Genéticos/administración & dosificación , Animales , Anticuerpos/sangre , Femenino , Vectores Genéticos/inmunología , Inyecciones Intramusculares , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , beta-Galactosidasa/genéticaRESUMEN
Adenovirus type 5 encodes a 14.7-kDa protein that protects infected cells from tumor necrosis factor-induced cytolysis by an unknown mechanism. In this report, we demonstrate that infection of cells with an adenovirus vector expressing Fas ligand induced rapid apoptosis that was blocked by coinfection with a virus expressing 14. 7K. Moreover, AdFasL/G infection resulted in the rapid activation of DEVD-specific caspases, and caspase activation was blocked by coinfection with Ad14.7/G. Cell death induced by the overexpression of Fas ligand, Fas-associated death domain-containing protein (FADD)/MORT1, or FADD-like interleukin-1beta-converting enzyme (FLICE)/caspase-8 in a virus-free system was efficiently blocked by 14.7K expression. Moreover, we demonstrate that 14.7K interacts with FLICE. These results support the idea that FLICE is a cellular target for the 14.7-kDa protein.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Adenoviridae/química , Apoptosis/fisiología , Caspasas , Cisteína Endopeptidasas/metabolismo , Glicoproteínas de Membrana/farmacología , Proteínas Virales/fisiología , Proteínas Portadoras/antagonistas & inhibidores , Caspasa 1 , Caspasa 8 , Caspasa 9 , Células Cultivadas , Activación Enzimática/fisiología , Proteína Ligando Fas , Proteína de Dominio de Muerte Asociada a Fas , Expresión Génica/genética , Genes Reporteros , Humanos , Glicoproteínas de Membrana/antagonistas & inhibidores , Microscopía Fluorescente , Microscopía de Contraste de Fase , Poli(ADP-Ribosa) Polimerasas/análisis , Serpinas/metabolismo , Transfección/genética , Proteínas Virales/metabolismoRESUMEN
Activating the protein-tyrosine kinase activity of v-Fps leads to the rapid transcriptional activation of the Egr-1 gene, which encodes a mitogen-responsive transcription factor. Activation of Egr-1 by v-Fps was insensitive to protein kinase C depletion, suggesting that a protein kinase C-independent signal activated by v-Fps leads to the induction of Egr-1. Expression of v-Fps in transient expression assays induced Egr-1 promoter activation. v-HaRas and v-Raf also activated the Egr-1 promoter. To characterize HaRas and Raf-1 involvement in v-Fps-induced Egr-1 expression, we used recently characterized dominant negative mutants of HaRas and Raf-1. v-Fps-induced Egr-1 promoter activation was inhibited by the dominant negative mutants of both HaRas and Raf-1. v-HaRas-induced Egr-1 promoter activation was blocked by the negative Raf-1 mutant; however, v-Raf-1-induced Egr-1 promoter activation was unaffected by the inhibitory HaRas mutant. These data suggest that v-Fps activates a protein kinase C-independent intracellular signaling pathway that is dependent on both HaRas and Raf-1, where Raf-1 functions downstream of HaRas.
Asunto(s)
Proteínas de Unión al ADN/biosíntesis , Proteínas Inmediatas-Precoces , Proteína Oncogénica p21(ras)/fisiología , Proteínas Tirosina Quinasas/fisiología , Proteínas Proto-Oncogénicas/fisiología , Transducción de Señal , Factores de Transcripción/biosíntesis , Animales , Virus del Sarcoma Aviar , Línea Celular , Línea Celular Transformada , Transformación Celular Viral , Proteína 1 de la Respuesta de Crecimiento Precoz , Activación Enzimática , Proteínas de Fusión gag-onc/fisiología , Regulación de la Expresión Génica , Mutación , Regiones Promotoras Genéticas , Proteína Quinasa C/fisiología , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-raf , Ratas , Proteínas Recombinantes de Fusión/biosíntesisRESUMEN
Activation of the cellular immune system and subsequent lysis of vector-transduced cells by adenovirus- or transgene-specific cytotoxic T lymphocytes have been shown to limit transgene expression in animal models. The adenovirus gp19K gene product associates with major histocompatibility complex class I proteins and prevents their maturation by sequestering them in the endoplasmic reticulum. gp19K has been shown to block the ability of adenovirus-specific cytotoxic T lymphocytes to recognize virus-infected cells in vitro. To determine if gp19K expression in an adenovirus vector would increase transgene persistence, a vector that replaces the E1 region of adenovirus with an expression cassette encoding both gp19K and beta-glucuronidase was constructed. This vector produced high levels of functional gp19K in infected cells. RNase protection analysis revealed efficient expression of the gp19K gene in the mouse lung. Enhanced persistence and increased beta-glucuronidase activity were observed in the lung and liver following delivery of the gp19K-expressing adenovirus vector in B10.HTG mice but not in BALB/c mice. Since gp19K binds to both class I alleles on B10.HTG mice but only one allele on BALB/c mice, these results suggest that the major histocompatibility complex class I haplotype of mice is important in determining the effectiveness of gp19K in vivo. Since gp19K has previously been shown to interact with every human major histocompatibility complex class I allele tested, the inclusion of gp19K in gene therapy vectors may increase vector persistence in human gene therapy trials.
Asunto(s)
Adenoviridae/fisiología , Proteínas E3 de Adenovirus/biosíntesis , Vectores Genéticos , Hígado/virología , Pulmón/virología , Ratones Transgénicos , Adenoviridae/genética , Animales , Línea Celular , Femenino , Genes MHC Clase I , Terapia Genética , Glucuronidasa/biosíntesis , Antígenos de Histocompatibilidad Clase I/metabolismo , Humanos , Riñón , Hígado/metabolismo , Pulmón/metabolismo , Neoplasias Pulmonares , Ratones , Ratones Endogámicos BALB C , Proteínas Recombinantes de Fusión/biosíntesis , Células Tumorales CultivadasRESUMEN
Protein kinases and phosphatases play an important role in signal transduction. In the T cell, activation via the T cell receptor-CD3 complex results in rapid tyrosine phosphorylation of proteins, as well as subsequent increases in serine/threonine phosphorylation. The Raf serine/threonine kinase has been implicated in many receptor signaling pathways, including those of platelet-derived growth factor, epidermal growth factor, insulin, and interleukin-2 receptors. We show here that Raf is associated with the T cell receptor-CD3 complex in unstimulated murine T cells. Using a COS cell expression system, we show that a hypophosphorylated form of Raf specifically associates with the CD3 gamma and delta chains but not with the CD3 epsilon or zeta chains. These results suggest that Raf mediates signal transduction from the gamma and delta chains of the T cell receptor-CD3 complex, analogous to the role played by ZAP-70 in signal transduction mediated by the zeta chain.
Asunto(s)
Complejo CD3/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Receptores de Antígenos de Linfocitos T/metabolismo , Linfocitos T/enzimología , Animales , Electroforesis en Gel Bidimensional , Sustancias Macromoleculares , Ratones , Fosfoproteínas/metabolismo , Proteínas Proto-Oncogénicas c-raf , Proteínas Recombinantes de Fusión , Proteínas Recombinantes , Transducción de SeñalRESUMEN
Deletion of the amino-terminal domain of Raf-1, which contains the Ras-binding region, results in the constitutive activation of the liberated Raf-1 catalytic domain in fibroblast cell lines. We demonstrate that the MEK kinase activity of the isolated Raf-1 catalytic domain, Raf-BXB, is not constitutively active, but is regulated in Jurkat T cells. Raf-BXB is activated by engaging the antigen receptor-CD3 complex, or treating cells with phorbol myristate acetate or okadaic acid. Increasing intracellular cAMP inhibits Raf-1 activation stimulated by phorbol myristate acetate, but not the activation of Raf-BXB. Serine 621, but not serine 499, is essential for Raf-BXB MEK kinase activity. Because Raf-BXB does not bind Ras, the data establishes a Ras-independent signal in directly regulating the activity of the Raf-1 catalytic domain.
Asunto(s)
Quinasa 1 de Quinasa de Quinasa MAP , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Linfocitos T/metabolismo , Proteínas ras/metabolismo , Secuencia de Aminoácidos , Animales , Anticuerpos , Anticuerpos Monoclonales , Sitios de Unión , Línea Celular , Activación Enzimática , Epítopos/análisis , Éteres Cíclicos/farmacología , Hemaglutininas/inmunología , Humanos , Toxinas Marinas , Ratones , Datos de Secuencia Molecular , Ácido Ocadaico , Oligopéptidos/inmunología , Oxazoles/farmacología , Fosfoproteínas Fosfatasas/antagonistas & inhibidores , Unión Proteica , Proteínas Proto-Oncogénicas c-raf , Complejo Receptor-CD3 del Antígeno de Linfocito T/metabolismo , Acetato de Tetradecanoilforbol/farmacología , Células Tumorales CultivadasRESUMEN
The serine/threonine protein kinase Raf-1 is a component of a conserved intracellular signaling cascade that controls responses to various extracellular stimuli. Transcription from several promoters, including the oncogene-responsive element in the polyomavirus enhancer, the c-fos promoter, as well as other AP-1- and Ets-dependent promoters, can be induced by Raf-1 kinase. Previously, we have shown that activated Raf-1 kinase transactivates the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and have identified the NF-kappaB binding motif as a Raf-1-responsive element (RafRE). We now report that Raf-1 kinase-induced transactivation from the HIV RafRE involves the purine-rich-repeat-binding protein (GABP), which is composed of two distinct subunits (alpha and beta). GABP alpha is an Ets oncogene-related DNA-binding protein, and GABP beta contains four ankyrin-like repeats that have been shown to be essential in protein-protein interactions. In electrophoretic mobility shift assays using nuclear extracts from human Jurkat T cells, a protein-DNA complex which was supershifted with antiserum against GABP alpha and GABP beta was observed. Purified recombinant GABP alpha and beta interact with the HIV RafRE as judged from DNA binding assays. Cotransfection experiments with GABP alpha and beta and Raf-1 kinase demonstrate synergistic transactivation of the HIV-1 promoter. Point mutations in the HIV RafRE abolished the Raf-1 kinase as well as GABP alpha- and beta-induced transactivation. The observed Raf-1-GABP synergism presumably involves phosphorylation of GABP subunits, as treatment of cells with Raf-1 kinase activators serum and 12-O-tetradecanoylphorbol-13-acetate increases phosphorylation of GABP in vivo. However, GABP is not a target of Raf-1 kinase; instead, it is a substrate of mitogen-activated protein kinase (MAPK/ERK), since in vitro phosphorylation of GABP alpha and beta was achieved by the reconstituted protein kinase cascade but not with purified Raf-1 or MEK. These results suggest that Raf-1 kinase- induced activation of the HIV-1 promoter is mediated by the classical cytoplasmic cascade resulting in MAPK/ERK-mediated phosphorylation of GABP alpha and beta. Because the HIV RafRE corresponds to a region within the promoter which is essential for regulation of HIV-1 expression, the data indicate that in addition to NK-kappaB, GABP transcription factors are important for induced expression of HIV.